Associated Papers
The spectrum of MAPK-ERK pathway genomic alterations in gynecologic malignancies: Opportunities for novel therapeutic approaches.
Nasioudis D et al.
Gynecologic Oncology, 2023
KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas.
Martianov AS et al.
International Journal of Molecular Sciences, 2023
36902296 (PubMed )
Supplement: ijms-24-04868-s001.zip › ijms-2214519-supplementary.pdf
High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patients.
Chao WR et al.
Taiwanese Journal of Obstetrics & Gynecology, 2021
High prevalence of TP53 loss and whole-genome doubling in early-onset colorectal cancer.
Kim JE et al.
Experimental & Molecular Medicine, 2021
33753878 (PubMed )
Supplement: 12276_2021_583_MOESM1_ESM.zip › 210226_BJX6JPRP_EMM2020836R_Supplelemtary_table_merged__1_.xls › Supplementary_Table_3
Uncommon mutational profiles of metastatic colorectal cancer detected during routine genotyping using next generation sequencing.
Franczak C et al.
Scientific Reports, 2019
Mutations in BRAF codons 594 and 596 predict good prognosis in melanoma.
Wu X et al.
Oncology Letters, 2017
The yin-yang of kinase activation and unfolding explains the peculiarity of Val600 in the activation segment of BRAF.
Kiel C et al.
Elife, 2016
26744778 (PubMed )
Supplement: elife-12814-supp1.xlsx › input_random_forest
Comparison of allelic discrimination by dHPLC, HRM, and TaqMan in the detection of BRAF mutation V600E.
Carbonell P et al.
The Journal of Molecular Diagnostics : Jmd, 2011
Select a paper to view details